CombiMatrix (CBMX) Stock Analysis

What CombiMatrix does

CombiMatrix Corporation operates as a biotechnology firm. Its primary focus is on developing innovative technology to manufacture DNA microarrays. These specialized arrays are instrumental in identifying and understanding the roles of genes, their mutations, and various proteins. The applications for this technology are extensive, reaching into fields such as genomics, proteomics, biosensor creation, pharmaceutical research and development (including drug discovery), medical diagnostics, combinatorial chemistry, material science, and nanotechnology.

Key metrics

ETFs linked to CBMX

Broad-market and Healthcare sector ETFs an investor holding CombiMatrix is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CBMX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for CombiMatrix?

CombiMatrix trades under the ticker CBMX on NASDAQ.

Which exchange is CBMX listed on?

CBMX is listed on NASDAQ.

What sector does CombiMatrix operate in?

CombiMatrix is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CBMX in a portfolio?

PortView shows CBMX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.